The experimental coronary vaccine of Modernna shows promising signs in the testing phase

Moderna INC has announced on Monday that experimental vaccine for COVID-19 is showing promising signs in the early phase of testing and is looking to push the vaccine to the advanced test phase in July. The vaccine, mRNA-1273, has also been generally safe and tolerated in the early phase of the study, has [...]
Moderna INC has announced on Monday that experimental vaccine for COVID-19 is showing promising signs in the early phase of testing and is looking to push the vaccine to the advanced test phase in July.
The vaccine, mRNA-1273, has also shown generally safe and tolerated in the early phase of the study, the company has said, the agency Reuters reports.












